Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Jul 28, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$12.9B
sum of reported positions
Reported positions
824
Changes vs prior quarter
610
87 new · 97 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 386 measured positions in 8 quarters, the typical new or larger position finished −3.2 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $10.8B | $12.9B |
| Positions | 834 | 824 |
| Biggest line | — | NVIDIA 5% |
| 1.37M |
| $478M |
| 3.7% |
| 1.01M | $378M | 2.9% |
| 642K | $266M | 2.1% |
| 1M | $238M | 1.8% |
| 649K | $220M | 1.7% |
| 732K | $210M | 1.6% |
| 180K | $206M | 1.6% |
| 626K | $206M | 1.6% |
| 570K | $200M | 1.6% |
ISHARES GOLD TR | 2.62M | $198M | 1.5% |
| 247K | $169M | 1.3% |
| 286K | $161M | 1.3% |
| 130K | $159M | 1.2% |
| 1.05M | $159M | 1.2% |
| 1.87M | $137M | 1.1% |
| 348K | $134M | 1.0% |
| 520K | $133M | 1.0% |
| 1.22M | $133M | 1.0% |
| 566K | $110M | 0.9% |
SPDR GOLD TR | 262K | $96.5M | 0.8% |
| 290K | $95.4M | 0.7% |
| 207K | $94M | 0.7% |
Home Depot (HD)
117K → 147K shares (+25%)
S&P Global (SPGI)
216K → 125K shares (−42%)
First Solar (FSLR)
211K → 214K shares (+1%)
CoStar Group (CSGP)
450K → 1.7M shares (+278%)
IBM (IBM)
142K → 177K shares (+25%)
Quanta Services (PWR)
82K → 68K shares (−17%)
Procter & Gamble (PG)
364K → 325K shares (−11%)
Hubbell Incorporated (HUBB)
69K → 92K shares (+32%)
Natera (NTRA)
130K → 173K shares (+34%)
Amgen (AMGN)
160K → 128K shares (−20%)
Sarepta Therapeutics (SRPT)
2.97M → 2.57M shares (−14%)
Sempra (SRE)
105K → 468K shares (+347%)
Abbott Laboratories (ABT)
541K → 465K shares (−14%)
Citigroup (C)
267K → 301K shares (+13%)
Morgan Stanley (MS)
135K → 202K shares (+50%)
Baker Hughes (BKR)
989K → 749K shares (−24%)
LKQ Corporation (LKQ)
2.7M → 1.57M shares (−42%)
PepsiCo (PEP)
383K → 295K shares (−23%)
Boston Scientific (BSX)
197K → 921K shares (+367%)
Kinsale Capital Group (KNSL)
127K → 120K shares (−6%)
STATE STR SPDR S&P 500 ETF T
42K → 53K shares (+27%)
Corteva (CTVA)
510K → 467K shares (−8%)
Texas Roadhouse (TXRH)
191K → 201K shares (+5%)
Booking Holdings (BKNG)
15K → 210K shares (+1257%)
Vertex Pharmaceuticals (VRTX)
92K → 77K shares (−17%)